|
n
|
85
|
44
| |
|
Age (years)
|
63 (60–67)
|
62 (58–67)
|
0.43
|
|
Sex (% female)
|
60
|
65
|
0.56
|
|
Ethnicity (Caucasoid/Negroid/Asiatic) (%)
|
68/28/4
|
73/27/0
|
0.60
|
|
Body mass index (kg m2)
|
29.6 (26.4–35.7)
|
28.8 (25.9–33.3)
|
0.35
|
|
Waist circumference (cm)
|
103 (97–115)
|
102 (96–110)
|
0.91
|
|
Arterial hypertension (%)
|
74
|
84
|
0.19
|
|
Smoking (%)
|
10.6
|
13.6
|
0.61
|
|
Total cholesterol (mg dL−1)
|
193 (165–234)
|
203 (167–233)
|
0.60
|
|
HDL (mg dL−1)
|
47 (38–56)
|
44 (35–52)
|
0.16
|
|
LDL (mg dL−1)
|
118 (94–150)
|
113 (89–147)
|
0.52
|
|
Triglycerides (mg dL−1)
|
144 (111–218)
|
184 (132–212)
|
0.05
|
|
Lipid accumulation product index
|
71.1 (54.4–110.4)
|
80.5 (60.1–151.4)
|
0.06
|
|
Diabetes status
|
|
Diabetes duration (years)
|
8 (4–13)
|
9 (4–20)
|
0.34
|
|
HbA1C (%)
|
7.3 (6.2–9.2)
|
7.5 (6.4–9.1)
|
0.94
|
|
(mmol.mol−1)
|
56 (44–77)
|
58 (46–76)
| |
|
eGFR < 60 mL.min−1.1.73m2 (%)
|
16
|
11
|
0.57
|
|
Distal symmetric polyneuropathy (%)
|
11.7
|
13.6
|
0.75
|
|
Inflammatory mediators
|
|
Leukotriene B4 (pg mL−1)
|
63.1 ± 16.4
|
71.5 ± 15.7
|
0.006
|
|
Tumor necrosis factor (pg mL−1)
|
1.9 ± 7.9
|
7.4 ± 36.0
|
0.001
|
|
Interleukin 1B (pg mL−1)
|
23.6 ± 106.3
|
9.2 ± 18.1
|
0.32
|
|
Interleukin 10 (pg mL−1)
|
5.5 ± 13.5
|
3.8 ± 14.2
|
0.002
|
